Senior Director, M&A and BD&L

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Senior Director, M&A and BD&L will report to the Executive Director, M&A and BD&L and be a member of the organization responsible for executing external transactions to grow and complement BMS’ R&D portfolio. The individual will be responsible for structuring, negotiating and executing a variety of transaction types, including mergers & acquisitions, research collaborations, licensing, externalizations (out-licensing, spin-outs), divestitures and equity investments.

This is a senior individual contributor role within the M&A and BD&L function, and the individual will be a key member of the M&A and BD&L team, working closely with the Leadership Team to support the function's overall performance. The Senior Director will manage their assigned work, lead the execution of significant transactions, and serve as a trusted representative of BMS in negotiations, internal governance, and strategic discussions.

The Senior Director is expected to provide strong peer leadership across the team and may mentor more junior colleagues; direct people management experience is not required for this role but is considered a plus.

• Lead (including structuring and negotiating) significant transactions on behalf of BMS, including M&A, licensing, and divestitures, under the guidance of the Executive Director;
  Drive the deal process from first contact with potential partners to execution of definitive agreements
• Support the M&A and BD&L Leadership team in managing the pipeline of M&A BD&L opportunities, contributing insights and analysis to inform strategic priorities, in partnership with R&D and Commercial colleagues
• Lead valuation, financial, and strategic analyses for assigned transactions, ensuring rigor and consistency in decision-making
• Partner with therapeutic area leads and other key personnel to define and execute strategies for acquiring/licensing external assets
• Serve as a skilled negotiator on assigned transactions, representing BMS's interests with rigor and professionalism
• Presents business rationale, analyses and proposals to senior stakeholders and supports the governance and approval process for assigned transactions end-to-end
• Build and maintain strong external relationships, including with investment banks, law firms, and target or partner company leadership
• Serve as a trusted advisor and thought partner to the Executive Directors and SVP, M&A and BD&L on assigned transactions and strategic priorities
• Provide peer leadership and mentorship to junior members of the M&A and BD&L team; direct management of a team is not required but is a plus

• Desired Bachelor's degree required; MBA, JD, PhD or other advanced business or science degree very strongly preferred
• 12 years of relevant experience in biotech or pharmaceutical companies, including a strong track record of identifying, evaluating, and executing transactions;
  Must have significant experience in M&A and BD&L, investment banking, or corporate development
• Financial Acumen:
  Highly skilled in financial analysis, valuation, and structuring deals; contributes to rigor and consistency in financial decision-making across the function
• Negot…